Schedule 13G ownership disclosure

PHASEBIO PHARMACEUTICALS INC

Security class unavailable · CUSIP: 717224109

Event date: 2021-05-12

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001019056-21-000312
Form type
SC 13G
Filer
PhaseBio Pharmaceuticals Inc
CIK
CIK 1169245
Filed
May 19, 2021
Reporting period
May 12, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub